Ensysce Biosciences, Inc. (ENSC) analyst actions
Rating and price-target actions on ENSC in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ENSC overview →
4 measured ENSC analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Ensysce Biosciences Initiates Live "Ask Me Anything" (AMA) Session Highlighting Growth and Future Plans | Press release | -2.25% | +2.33% | |
| Ensysce Biosciences Initiates Review of Strategic Alternatives to Enhance Shareholder Value | Press release | -2.42% | -1.17% | |
| Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid | Press release | -2.98% | +5.97% | |
| Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614 - A Next-Generation Opioid - Designed to Deliver Powerful Pain Relief and Reduce Abuse | Press release | +0.70% | +1.41% |
Keep exploring
More ENSC: earnings → · SEC filings → · ENSC overview →